Treatment of Nausea in First Trimester of Pregnancy
For first trimester nausea and vomiting of pregnancy (NVP), the recommended stepwise treatment begins with dietary modifications, followed by vitamin B6 (pyridoxine) alone or in combination with doxylamine as first-line pharmacologic therapy, with other medications reserved for more severe cases. 1
Initial Assessment
- Evaluate severity using the Motherisk Pregnancy-Unique Quantification of Emesis (PUQE) score:
- Mild: ≤6 points
- Moderate: 7-12 points
- Severe: ≥13 points
- (Score based on duration of nausea, frequency of vomiting, and frequency of retching in past 12 hours) 1
Treatment Algorithm
Step 1: Non-pharmacologic Approaches
- Dietary modifications:
- Small, frequent, bland meals
- BRAT diet (bananas, rice, applesauce, toast)
- High-protein, low-fat meals
- Avoid spicy, fatty, acidic, and fried foods
- Identify and avoid specific triggers (certain foods with strong odors or activities) 1
Step 2: First-line Pharmacologic Treatment
Vitamin B6 (pyridoxine):
Doxylamine and pyridoxine combination:
Step 3: Second-line Pharmacologic Treatment
- H1-receptor antagonists (if above treatments are insufficient):
- Doxylamine (as mentioned above)
- Promethazine
- Dimenhydrinate 1
Step 4: For Moderate to Severe Cases
- Metoclopramide:
Special Considerations
Early intervention is crucial: Prompt treatment of NVP may prevent progression to hyperemesis gravidarum (HG), which affects 0.3-2% of pregnant women 1
Hyperemesis gravidarum warning signs:
- Dehydration
- Weight loss >5% of pre-pregnancy weight
- Electrolyte imbalances
- If suspected, evaluate for signs of dehydration and consider hospitalization for IV hydration 1
Thiamine supplementation: For prolonged vomiting, consider thiamine 300 mg daily with vitamin B complex to prevent Wernicke encephalopathy 1
Safety Profile
- Vitamin B6 has established safety during pregnancy for doses up to 40-60 mg/day 2, 5
- The doxylamine-pyridoxine combination has substantial safety data and FDA Pregnancy Category A status 3
- Metoclopramide should be used under medical supervision and therapy should not exceed 12 weeks 4
Monitoring
- Reassess symptom severity regularly using the PUQE score
- Monitor for adequate hydration and nutrition
- For patients with severe symptoms or hyperemesis gravidarum, consider referral to specialist care for multidisciplinary management 1
Pitfalls to Avoid
- Delaying treatment, which may lead to progression to hyperemesis gravidarum
- Inadequate hydration management
- Overlooking potential vitamin deficiencies, particularly thiamine, in cases of prolonged vomiting
- Using medications beyond recommended durations (e.g., metoclopramide therapy should not exceed 12 weeks) 1, 4